January 2025 Br J Cardiol 2025;32:26–30 doi:10.5837/bjc.2025.004
Hibba Kurdi, Henry Procter, Matthew Aldred, Katie Linden, Angela Langton, Akriti Naraen, Kathryn Abernethy, Sabrina Nordin, Ashwin Roy, Ben Leach, James Moon, Derralynn Hughes
Introduction Fabry disease is a rare X-chromosome-linked disorder that results from alpha-galactosidase A enzyme deficiency. It is broadly divided into classical (earlier onset, low enzyme activity) and non-classical (milder, later-onset and some residual activity). It is underdiagnosed despite the availability of diagnostic tests, such as blood (plasma or leucocyte alpha-galactosidase A enzyme) and genetic testing. Due to its heterogeneous nature as a multi-system disorder, Fabry disease (FD) is rarely considered. Patients often present with non-specific symptoms, such as fatigue and gastrointestinal symptoms akin to irritable bowel, taking
April 2021 doi:10.5837/bjc.2021.015
Joseph M Krepp, Richard Katz, Rachel Volke, Angela Ryan, Gurusher Panjrath
Case presentation An 83-year-old man presented with progressive shortness of breath and moderate lower extremity oedema over a period of several months. His past medical history is notable for hypertension, non-insulin dependent diabetes, bilateral carpal tunnel syndrome and aortic stenosis. At the time of presentation he was found to have new-onset atrial flutter with rapid ventricular response. An echocardiogram demonstrated moderate concentric left ventricular hypertrophy and moderate aortic stenosis with an ejection fraction of 55% and mildly reduced right ventricular function. A left heart catheterisation confirmed the presence of modera
March 2014 Br J Cardiol 2014;21:17–9
Heather Wetherell
(more…)
July 2004 Br J Cardiol 2004;11:315-20
Michael Kirby, Rubin Minhas
No content available
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits